Use of allokin-alpha in the treatment of chronic herpesvirus infection in adults
- 作者: Rakitianskaya I.A1, Riabova T.S.1,2, Kalashnikova A.A.3
-
隶属关系:
- City Outpatient Unit of Allergology, Immunology, and Clinical Transfusiology, City Polyclinic One Hundred and Twelve
- S.M. Kirov Military Medical Academy
- A.M. Nikiforov All-Russian Center of Emergency and Radiation Medicine, Russian Ministry for Civil Defense, Emergencies and Elimination of Consequences of Natural Disasters
- 期: 卷 9, 编号 4 (2019)
- 页面: 84-94
- 栏目: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/287417
- DOI: https://doi.org/10.18565/epidem.2019.9.4.84-94
- ID: 287417
如何引用文章
详细
全文:
作者简介
I. Rakitianskaya
City Outpatient Unit of Allergology, Immunology, and Clinical Transfusiology, City Polyclinic One Hundred and Twelve
Email: tat-akyla@inbox.ru
MD, Clinical Immunologist; Professor, Outpatient Unit of Allergology, Immunology, and Clinical Transfusiology, Prof. Saint Petersburg, Russia
Tatiana Riabova
City Outpatient Unit of Allergology, Immunology, and Clinical Transfusiology, City Polyclinic One Hundred and Twelve; S.M. Kirov Military Medical Academy
Email: tita74@mail.ru
MD, Nephrologist; Associate Professor, Department of Nephrology and Efferent Therapy, S.M. Kirov Military Medical Academy; Consulting Cardiologist, Outpatient Unit of Allergology, Immunology, and Clinical Transfusiology, City Polyclinic One Hundred and Twelve Saint Petersburg, Russia
Anastasia Kalashnikova
A.M. Nikiforov All-Russian Center of Emergency and Radiation Medicine, Russian Ministry for Civil Defense, Emergencies and Elimination of Consequences of Natural Disasters
Email: petkova_nas@mail.ru
Cand Biol. Sci., Senior Researcher, Laboratory of Clinical Immunology Saint Petersburg, Russia
参考
- Cuomo L., Angeloni A., Zompetta C., Cirone M., Calogero A., Frati L., Ragona G., Faggioni A. Human herpesvirus 6 variant A, but not variant B, infects EBV-positive B lymphoid cells, activating the latent EBV genome through a BZLF-1-dependent mechanism. AIDS Res. Hum. Retrovir. 1995; (11): 1241-5.
- Flamand L., Menezes J. Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6. J. Virol. 1996; 70(3): 1784-91.
- Flamand L., Stefanescu L.I., Ablashi D.V., Menezes J. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6. J. Virol. 1993; 67: 6768-77.
- Bertram G.N., Dreiner G.R., Krueger A., Ramon D.V., Ablashi S., Salahuddin Z., Balachandram N. Frequent double infection with Epstein-Barr virus and human herpesvirus-6 in patients with acute infectious mononucleosis. In Vivo 1991; (5): 271-27.
- Pellett P.E., Ablashi D.V., Ambros P.F., Agut H., Caserta M.T., Descamps V. et al. Chromosomally integrated human herpesvirus 6: questions and answers. Rev. Med. Virol. 2012; 22(3): 144-55. doi: 10.1002/rmv.715.
- Fitzgerald-Bocarsly P., Dai J., Singh S. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev. 2008; 19: 3-19. doi: 10.1016/j.cytogfr.2007.10.006.
- Ivashkiv L.B., Donlin L.T. Regulation of type I interferon responses. Nat. Rev. Immunol. 2014; 14: 36-49. doi: 10.1038/nri3581.
- Areste C., Blackbourn D.J. Modulation of the immune system by Kaposi’s sarcoma-associatedherpesvirus. Trends Microbiol. 2009; 17: 119-29. doi: 10.1016/j.tim.2008.12.001.
- Fenimore J., Young H.A. Regulation of interferon-γ expression. Adv. Exp. Med. Biol. 2016; 941: 1-19.
- Bernabei P., Allione A., Rigamonti L., Bosticardo M., Losana G., Borghi I., Forni G., Novelli F. Regulation of interferon-gamma receptor (INF-gammaR) chains: a peculiar way to rule the life and death of human lymphocytes. Eur. Cytokine Netw. 2001; 12(1): 6-14.
- Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 2008; 89: 1-47. doi: 10.1099/vir.0.83391-0
- Thomas D., Blakqori G., Wagner V., Banholzer M., Kessler N., Elliott R.M., Haller O., Weber F. Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist. J. Biol. Chem. 2004; 279: 31471-7.
- Haller O., Kochs G., Weber F. The interferon response circuit: Induction and suppression by pathogenic viruses. Virology 2006; 344 (Issue 1): 119-30. https://doi. org/10.1016/j.virol.2005.09.024
- Shabman R.S., Morrison T.E., Moore C., White L., Suthar M.S., Hueston L., Rulli N., Lidbury B., Ting J.P. Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses. J. Virol. 2007; 81: 237-47.
- Carlos T.S., Fearns R., Randall R.E. Interferon-induced alterations in the pattern of parainfluenza virus 5 transcription and protein synthesis and the induction of virus inclusion bodies. J. Virol. 2005; 79: 14112-21.
- Langland J.O., Cameron J.M., Heck M.C., Jancovich J.K., Jacobs B. L. Inhibition of PKR by RNA and DNA viruses. Virus Res. 2006; 119: 100-10.
- Xu D., Brumm K., Zhang L. The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production. J. Biol. Chem. 2006; 281: 9163-9.
- Mayne M., Cheadle C., Soldan S., Cermelli C., Yamano Y., Akhyani N., Nagel J. E., Taub D.D., Becker K.G., Jacobson S. Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms. J. Virol. 2001; 75: 11641-50.
- Сологуб Т.В., Цветков В.В., Деева Э.Г. Интерферон-гамма - цитокин с противовирусной, иммуномодулирующей и противоопухолевой активностью. Российский медико-биологический вестник имени академика И.П. Павлова 2014; (3): 56-60. Sologub T.V., Tsvetkov VV., Deeva E.G. Interferon-gamma - cytokine with antiviral, immunomodulating and antitumor activity. Rossiyskiy mediko-biologicheskiy vestnik imeni akademika I.P. Pavlova 2014; (3): 56-60. (In Russ.).
- Kuczer M., Dziubasik K., Midak-Siewirska A., Zahorska R., Euczak M., KonopiAska D. Studies of insect peptides alloferon, Any-GS and their analogues. Synthesis and antiherpes activity. J. Pept. Sci. 2010; 16(4): 186-9.
- Kuczer M., Majewska A., Zahorska R. New alloferon analogues: synthesis and antiviral properties. Chem. Biol. Drug Des. 2013; 81(2): 302-9. doi: 10.1111/cbdd.12020
- Kuczer M., Czarniewska А., Majewska A., Rözanowska M., RosiAski G., Lisowski M. Novel analogs of alloferon: Synthesis, conformational studies, pro-apoptotic and antiviral activity. Bioorg. Chem. 2016; 66: 12-20. doi: 10.1016/j.bioorg.2016.03.002
- Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 1994; 121(12): 953-9. doi: 10.7326/0003-4819-121-12-199412150-00009
- Holmes G.P., Kaplan J.E., Gantz N.M., Komaroff A.L., Schonberger L.B., Straus S.E., Jones J.F., Dubois R.E., Cunningham-Rundles C., Pahwa S. Chronic fatigue syndrome: a working case definition. Ann. Intern. Med. 1988; 108(3): 387-9.
- Staines D.R. Postulated Vasoactive Neuropeptide Autoimmunity in Fatigue-Related Conditions: A Brief Review and Hypothesis. Clin. Dev. Immunol. 2006; 13(1): 25-39. doi: 10.1080/17402520600568252
- Griffith J.P., Zarrouf А. A systematic review of chronic fatigue syndrome: don’t assume it’s depression. J. Clin. Psychiatry 2008; (1): 120-8. doi: 10.4088/pcc.v10n0206
- Kimura H., Cohen J.I. Chronic Active Epstein-Barr Virus Disease. Front. Immunol. 2017; 28: 1-6. https://doi. org/10.3389/fimmu.2017.01867
- Kimura H. Pathogenesis ofchronic active Epstein-Barrvirus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev. Med. Virol. 2006; 16: 251-61. doi: 10.1002/rmv.505
- Kimura H., Morishima T., Kanegane H., Ohga S., Hoshino Y., Maeda A. Prognostic factors for chronic active Epstein-Barr virus infection. J. Infect. Dis. 2003; 187: 527-33. doi: 10.1086/367988
- De Bolle L., Naesens L., De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin. Microbiol. Rev. 2005; 18: 217-45.
- De Filippis L., Foglieni C., Silva S., Vescovi A.L., Lusso P., Malnati M.S. Differentiated human neural stem cells: a new ex vivo model to study HHV-6 infection of the central nervous system. J. Clin. Virol. 2006; 37(Suppl 1): 27-32.
- Kwok H., Chan K.W., Chan K.H., Chiang A.K. Distribution, persistence and interchange of Epstein-Barr virus strains among PBMC, plasma and saliva of primary infection subjects. PLoSOne 2015; 10(3): e0120710
- De Clerq E. Antivirals: current state of the art. Future Virol. 2008; 3(4): 393-405. doi: 10.2217/17460794.3.4.393
- Findlay E.G., Currie S.M., Davidson D.J. Cationic host defence peptides: potential as antiviral therapeutics. BioDrugs 2013; 27: 479-93. doi: 10.1007/s40259-013-0039-0
- Chernysh S., Kim S. I., Bekker G., PleskachV.A., Filatova N.A., Anikin V.B., Platonov V.G., Bulet P. Antiviral and antitumor peptides from insects. Proc. Natl. Acad. Sci. USA 2002; 99(20): 12628-32. DOI: [10.1073/pnas. 192301899]
- Lee N., Bae S., Kim H., Kong J.M., Kim H.R., Cho B.J., Kim S.J., Seok S.H., Hwang Y.I., Kim S., Kang J.S., Lee W.J. Inhibition of lytic reactivation of Kaposi’s sarcoma-associated herpesvirus by alloferon. Antivir. Ther. 2011; 16: 17-26. doi: 10.3851/IMP1709
- Bae S., Oh K., Kim H., Kim Y., Kim H.R., Hwang Y.I., Lee D.S., Kang J.S., Lee W.J. The effect of alloferon on the enhancement of NK cell cytotoxicity against cancer via the up-regulation of perforin/granzyme B secretion. Immunobiology 2013; 218(8): 1026-33. DOI: 10.1016/j. imbio.2012.12.002
- Kim Y., Lee S.K., Bae S., Kim H., Park Y., Chu N.K., Kim S.G., Kim H.R., Hwang Y.I., Kang J.S., Lee W.J. The anti-inflammatory effect of alloferon on UVB-induced skin inflammation through the down-regulation of pro-inflammatory cytokines. Immunol. Lett. 2013; 149: 110-18.
- Agut H., Bonnafous P., Gautheret-Dejean A. Human Herpesviruses 6A, 6B, and 7. Microbiol. Spectr. 2016; 4(3). doi: 10.1128/microbiolspec.DMIH2-0007-2015
- Коновалова Н.В., Храменко Н.И., Величко Л.Н., Юрченко Л.А. Роль уровня интерферонов-α и -γ в крови больных увеитами вирусной этиологии под влиянием лечения препаратом аллокин-альфа. Точка зрения. Восток -Запад 2018; (4): 26-9. DOI: https://doi.org/10.25276/ 2410-1257-2018-4-26-29
- Зароченцева Н.В., Аркашян А.К., Титченко Ю.П.. Меньшикова Н.С., Баринова И.В., Ушакова С.В. Применение препарата аллокина-альфа в комплексной терапии пациенток с хроническим эндометритом и привычным невынашиванием беременности. Российский вестник акушера-гинеколога 2014; (4): 73-80
- Черныш С.И. Аллокины (цитокиноподобные пептиды насекомых) как модуляторы иммунного ответа человека и других млекопитающих. Российский иммунологический журнал 2004; (9): 36
- Haller O., Weber F. The interferon response circuit in antiviral host defense. Verh. К Acad. Geneeskd Belg. 2009; 71(1-2): 73-86